U.S. Healthtech Stock News

If you are wondering whether Napco Security Technologies' current share price reflects its true worth, you are not alone. Many investors are trying to work out if the recent run still leaves room for value. The stock closed at US$46.61, with returns of 1.6% over the last 7 days, 26.3% over 30 days, 12.6% year to date and 92.9% over 1 year. The 3 year and 5 year returns stand at 47.4% and 182.8% respectively. Recent news coverage has largely focused on Napco Security Technologies as a...

American Superconductor (AMSC) is back in focus after reporting fiscal third quarter earnings per share of $2.81 on revenue that was 20% higher than a year earlier, far above prior expectations. See our latest analysis for American Superconductor. Despite the earnings surprise, American Superconductor’s share price has recently cooled, with a 1-day share price return of a 6% decline and a 7-day share price return of a 4% decline, following a 30-day share price return of 8.9% and a 1-year...

In late February 2026, Assurant reported its fourth quarter and full-year 2025 results, marking a ninth consecutive year of profitable growth and announcing a US$250 million to US$350 million share repurchase range for 2026. Positive coverage from major firms, including reiterated Hold and Buy ratings, underscored how earnings resilience and capital return plans are shaping investor perceptions of Assurant’s business quality. Next, we’ll examine how Assurant’s sustained profitable growth and...

L3Harris Technologies (NYSE:LHX) secured its largest full rate production contract for submarine communications shipsets, tied to critical naval platforms. The company won a new contract to supply components for the THAAD missile defense system, reinforcing its role in U.S. missile defense infrastructure. L3Harris announced a major manufacturing expansion, with billions earmarked to increase solid rocket motor output across U.S. facilities. The company plans an IPO for its Missile Solutions...

Why Indivior Pharmaceuticals (INDV) is on investors’ radar today Indivior Pharmaceuticals (INDV) focuses on treatments for opioid use disorder and overdose, and recent share performance may have prompted investors to reassess how its current valuation lines up with its fundamentals. See our latest analysis for Indivior Pharmaceuticals. At a share price of $32.72, Indivior Pharmaceuticals has seen recent share price pressure, with a 1 month share price return of 7.52% and a year to date share...

If you are wondering whether BlackLine is starting to look interesting at today’s price, this article will walk through what that current market value might be implying about the business. BlackLine’s share price recently closed at US$35.25, with returns of 2.5% decline over 7 days, 24.1% decline over 30 days, 34.5% decline year to date, 27.0% decline over 1 year, 50.0% decline over 3 years, and 68.4% decline over 5 years that may have reshaped how the market views its potential and...

Iowa Attorney General Brenna Bird has sued General Motors and its OnStar unit, alleging they collected and sold detailed driving data from Iowans without consent since 2015, in violation of the Iowa Consumer Fraud Act. The case spotlights how GM’s push to monetize connected-vehicle data through services like OnStar can collide with evolving expectations around privacy and transparency. We’ll now examine how this alleged misuse of OnStar driving data could affect GM’s investment narrative...

If you are looking at NovoCure and wondering whether the recent share price makes sense, this article will walk through what that price might be implying about the stock's value. The shares last closed at US$13.67, with returns of 20.3% over the past 7 days and 10.2% over 30 days, set against a 4.2% return year to date and a 28.3% decline over 1 year, and an 82.5% and 89.4% decline over 3 and 5 years respectively. Recent news coverage around NovoCure has focused on the company as a Nasdaq...

ZoomInfo Technologies (GTM) moved back into focus after Nvidia CEO Jensen Huang argued that artificial intelligence is more likely to support, not threaten, enterprise software providers such as ZoomInfo. See our latest analysis for ZoomInfo Technologies. Even after reacting positively to Jensen Huang’s comments, ZoomInfo’s share price remains under pressure, with a 30 day share price return of 22.86% and a 1 year total shareholder return of 46.74%. This indicates that recent momentum has...

In February 2026, Armstrong World Industries reported Q4 2025 results showing higher year-on-year sales and earnings, but both revenue and EPS came in below analyst expectations, and the company issued 2026 earnings guidance that was softer than the market had anticipated. At the same time, Armstrong outlined 2026 targets for net sales of US$1.75–US$1.79 billion and net earnings of US$340–US$349 million, giving investors clearer insight into how management sees demand, margins, and capital...

Carnival Corporation & (CCL) is back in focus after rolling out its fleetwide Carnival Millions digital lottery, while simultaneously rerouting ships away from Puerto Vallarta and canceling some Mexico excursions in response to cartel related violence. See our latest analysis for Carnival Corporation &. Recent news on Carnival Millions and route adjustments sits against a share price of US$31.55, with a 30 day share price return of 5.1% and a 90 day share price return of 21.7%. The 1 year...

If you are wondering whether Qnity Electronics at around US$126.76 is still a fair deal or already priced for perfection, you are in the right place. The stock has been active recently, with returns of 11.7% over 7 days, 31.8% over 30 days and 49.2% year to date, which can change how the market is thinking about both its potential and its risks. Recent coverage of Qnity Electronics has focused on its position within the semiconductor space and how investors are reacting to its current...

If you are looking at Targa Resources and wondering whether the current share price still makes sense, you are not alone. The stock last closed at US$235.80, with returns of 1.9% over 7 days, 17.3% over 30 days, 26.3% year to date and 19.6% over 1 year, while the 3 year return is very large and the 5 year return is also very large. Recent news flow around Targa Resources has focused on its position in the energy infrastructure space and how investor sentiment has been reflecting that...

If you are wondering whether Recursion Pharmaceuticals' current share price makes sense, the key question is how that price compares with what the business could reasonably be worth. The stock last closed at US$3.67, with a 7 day return of 7.3%, a 30 day return decline of 12.4%, a year to date return decline of 12.6%, and a 1 year return decline of 51.1%. These figures will shape how many investors think about its potential and risk today. Recent coverage has focused on Recursion...

GoodRx Holdings recently reported fourth-quarter 2025 results, issued 2026 revenue guidance of US$750 million to US$780 million, updated progress on its share buyback, filed a US$74.72 million shelf registration for an ESOP-related Class A stock offering, and disclosed several analyst rating changes. The company also launched GoodRx Employer Direct, a new program that lets employers directly subsidize high-cost drugs like GLP-1s at the pharmacy counter, potentially widening GoodRx’s role in...

Without a clear single event driving headlines, Stellar Bancorp (STEL) is drawing attention as investors weigh its recent share performance, current valuation signals, and the bank’s underlying earnings and revenue profile. See our latest analysis for Stellar Bancorp. At a share price of $37.66, Stellar Bancorp has seen a 22.43% year to date share price return and a 32.00% total shareholder return over the past year, with recent weekly softness tempering the strong 90 day share price momentum...

National HealthCare Corporation reported past fourth-quarter 2025 revenue of US$386.51 million and net income of US$24.85 million, with full‑year 2025 revenue of US$1.52 billion and net income of US$120.02 million, all higher than the prior year. The company highlighted that growth was supported both by higher same‑facility revenues and the contribution from its White Oak Manor acquisition, underscoring the role of expansion alongside core operations in its 2025 results. With this backdrop...

Construction Partners (ROAD) has caught investor attention after its share price moved in recent trading, with recent returns over the past month and past 3 months putting its performance firmly under the spotlight. See our latest analysis for Construction Partners. That near term move sits on top of a much stronger run, with a 22.29% 1 month share price return and a 24.22% 3 month share price return feeding into a 1 year total shareholder return of 85.18%, which suggests momentum has been...

In February 2026, Global-E Online Ltd. reported fourth-quarter 2025 sales of US$336.66 million and net income of US$62.45 million, issued full-year 2026 revenue guidance of US$1.21–US$1.27 billion, and confirmed completion of a US$72 million share repurchase covering 1,938,665 shares. The combination of stronger profitability, higher revenue guidance, and a completed buyback program highlights management’s confidence in Global-E Online’s financial position and growth plans. Next, we’ll...

In February 2026, Six Flags Entertainment reported its fourth-quarter and full-year 2025 results, showing quarterly revenue of US$116.97 million and a quarterly net loss of US$92.38 million, while full-year revenue reached US$3.10 billion with a much larger full-year net loss of US$1.60 billion. The earnings release, combined with Broyhill Asset Management’s exit after citing integration challenges, weather exposure, pressure on lower-income guests, and leadership changes, has sharpened...

Recent commentary on Alexander's (ALX) argues that its vacant retail space is part of a plan to unlock value, not lasting damage, with a refinancing improving liquidity and supporting ongoing dividend payments. See our latest analysis for Alexander's. At a share price of $234.62, Alexander's has seen a 9.86% 90 day share price return and a 7.20% year to date share price return, while the 1 year total shareholder return sits at 18.67%, which reflects recent performance across different time...

In February 2026, Centuri Holdings reported fourth-quarter 2025 results showing revenue of US$858.6 million and net income of US$30.18 million, contributing to full-year revenue of US$2.98 billion and net income of US$22.4 million, alongside issuing 2026 revenue guidance of US$3.24 billion to US$3.54 billion. Management also highlighted a backlog of about US$5.9 billion and a roughly US$13 billion bidding pipeline, indicating substantial contracted and potential work already identified for...

GXO Logistics, Inc. announced that it successfully launched a multi-year partnership with lingerie retailer Hunkemöller, taking over its B2B logistics operations in Almere from January 1, 2026, using a 32,000-square-meter, highly automated site to support pan-European distribution. This is Hunkemöller’s first move to outsource B2B logistics, underscoring GXO’s role as a technology-led logistics partner integrating robotics and shuttle systems into a single, large-scale European hub. Next,...

Why Pacira BioSciences is on investors’ radar today Pacira BioSciences (PCRX) has been drawing attention after a mixed share price pattern, with a 6.7% gain over the past month contrasting with negative returns over the past 3 months and year to date. See our latest analysis for Pacira BioSciences. At the current share price of $21.91, Pacira BioSciences shows a mixed picture, with a 6.7% 30 day share price return set against a 10.4% year to date share price decline and a 68.3% five year...